检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
机构地区:[1]中国医科大学附属第一医院胸外科,辽宁沈阳110001
出 处:《现代肿瘤医学》2013年第2期257-260,共4页Journal of Modern Oncology
基 金:辽宁省科技攻关项目资助(编号:2009225008-2)
摘 要:目的:检测β-榄香烯乳对肺腺癌A549细胞株放射增敏作用并初步探讨其作用机制。方法:四氮唑蓝比色分析法(MTT法)检测β-榄香烯乳对A549细胞增殖的半数抑制浓度(IC50);将细胞分为对照组(C)、照射组(R)、β-榄香烯乳组(0.1×IC50、0.2×IC50)及β-榄香烯乳联合照射组(0.1×IC50+R、0.2×IC50+R),用不同浓度的β-榄香烯乳处理细胞24h后照射,流式细胞仪检测细胞凋亡率。实时定量PCR技术(real-time PCR)检测细胞Livin基因mRNA表达量。结果:MTT法测得β-榄香烯乳对A549细胞增殖的IC50值为115μg/ml;流式细胞仪检测β-榄香烯乳联合照射组细胞凋亡率明显高于单纯照射组及β-榄香烯乳组(P<0.05);β-榄香烯乳联合照射组细胞Livin基因mRNA表达量较照射组明显下降(P<0.01)。结论:β-榄香烯乳可抑制A549细胞增殖,促进A549细胞凋亡和抑制Livin基因mRNA表达,其放射增敏机制可能与这些作用有关。Objective: To study the effect of β - elemene combined with radiotherapy on the apoptosis of lung adenocarcinoma cell line A549 and mechanism. Methods: A549 cells were divided into the control group ( C ), irridation group( R), β -elemene group(0.1 ×IC50 and 0.2 × IC50 ) and β -elemene combined with irradiation group (0.1 × IC50 + R and 0.2 ×IC50 + R). IC50 was obtained through MTF method. Cell apoptosis was detected with flow eytometry. The expression level of Livin mRNA was detected by real - time PCR. Results : MTT assay showed that IC50 value of A549 cells was 115μg/ml. The flow cytometry confirmed that the apoptosis were significantly increased under the effect of β - elemene, statistically different from those in the control group ( P 〈 0.05 ). The expression level of Livin mRNA in β - elemene with radiotherapy group was declined significantly, statistically different from those in the control group( P 〈 0.01 ). Conclusion:The radiosensitization effect of β -elemene oh A549 cells is to inhibit the proliferation of A549 cells, associated with induction of cell apoptosis and down - regulation of Livin mRNA expression. These effects may be related to radiosensitization mechanism.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:18.216.1.197